Cell And Gene Therapy Market
Cell And Gene Therapy Market - Global Industry Assessment & Forecast
#
Pages:
250
Base Year:
2023
Dec - 2024
Format:
Report Code:
VMR-3924
Segments Covered
By
Therapy Type Cell Therapy, Gene Therapy
-
By
Therapeutic Class Cardiovascular Disease, Cancer, Genetic Disorder, Rare Diseases, Oncology, Hematology, Ophthalmology, Infectious Disease, Neurological Disorders, Others
-
By
Delivery Method In Vivo, Ex Vivo
-
By
End Users Hospitals, Cancer Care Centers, Others
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2023 |
| Forecast
Years:
|
2024 - 2032 |
 Historical
Years:
|
2018 - 2022 |
 Revenue
2023: |
USD 20.5 Billion |
 Revenue 2032:
|
USD 128.8 Billion |
 Revenue CAGR
(2024 - 2032): |
18.2% |
Fastest Growing Region (2024 -
2032)
|
Asia Pacific |
Largest Region (2023):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Cell And Gene Therapy Market Segment Analysis
- Cell And Gene Therapy Therapy Type Outlook (Revenue, USD Million, 2018 - 2030)
- Cell Therapy
- Gene Therapy
- Cell And Gene Therapy Therapeutic Class Outlook (Revenue, USD Million, 2018 - 2030)
- Cardiovascular Disease
- Cancer
- Genetic Disorder
- Rare Diseases
- Oncology
- Hematology
- Ophthalmology
- Infectious Disease
- Neurological Disorders
- Others
- Cell And Gene Therapy Delivery Method Outlook (Revenue, USD Million, 2018 - 2030)
- In Vivo
- Ex Vivo
- Cell And Gene Therapy End Users Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Cancer Care Centers
- Others
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Cell And Gene Therapy Market, by Therapy Type
- Cell Therapy
- Gene Therapy
-
North America Cell And Gene Therapy Market, by Therapeutic Class
- Cardiovascular Disease
- Cancer
- Genetic Disorder
- Rare Diseases
- Oncology
- Hematology
- Ophthalmology
- Infectious Disease
- Neurological Disorders
- Others
-
North America Cell And Gene Therapy Market, by Delivery Method
- In Vivo
- Ex Vivo
-
North America Cell And Gene Therapy Market, by End Users
- Hospitals
- Cancer Care Centers
- Others
- U.S.
- U.S. Cell And Gene Therapy Market, by Therapy Type
- Cell Therapy
- Gene Therapy
- U.S. Cell And Gene Therapy Market, by Therapeutic Class
- Cardiovascular Disease
- Cancer
- Genetic Disorder
- Rare Diseases
- Oncology
- Hematology
- Ophthalmology
- Infectious Disease
- Neurological Disorders
- Others
- U.S. Cell And Gene Therapy Market, by Delivery Method
- In Vivo
- Ex Vivo
- U.S. Cell And Gene Therapy Market, by End Users
- Hospitals
- Cancer Care Centers
- Others
- U.S. Cell And Gene Therapy Market, by Therapy Type
- Canada
- Canada Cell And Gene Therapy Market, by Therapy Type
- Cell Therapy
- Gene Therapy
- Canada Cell And Gene Therapy Market, by Therapeutic Class
- Cardiovascular Disease
- Cancer
- Genetic Disorder
- Rare Diseases
- Oncology
- Hematology
- Ophthalmology
- Infectious Disease
- Neurological Disorders
- Others
- Canada Cell And Gene Therapy Market, by Delivery Method
- In Vivo
- Ex Vivo
- Canada Cell And Gene Therapy Market, by End Users
- Hospitals
- Cancer Care Centers
- Others
- Canada Cell And Gene Therapy Market, by Therapy Type
-
Mexico
- Mexico Cell And Gene Therapy Market, by Therapy Type
- Cell Therapy
- Gene Therapy
- Mexico Cell And Gene Therapy Market, by Therapeutic Class
- Cardiovascular Disease
- Cancer
- Genetic Disorder
- Rare Diseases
- Oncology
- Hematology
- Ophthalmology
- Infectious Disease
- Neurological Disorders
- Others
- Mexico Cell And Gene Therapy Market, by Delivery Method
- In Vivo
- Ex Vivo
- Mexico Cell And Gene Therapy Market, by End Users
- Hospitals
- Cancer Care Centers
- Others
- Mexico Cell And Gene Therapy Market, by Therapy Type
-
North America Cell And Gene Therapy Market, by Therapy Type
- Europe
-
Europe Cell And Gene Therapy Market, by Therapy Type
- Cell Therapy
- Gene Therapy
-
Europe Cell And Gene Therapy Market, by Therapeutic Class
- Cardiovascular Disease
- Cancer
- Genetic Disorder
- Rare Diseases
- Oncology
- Hematology
- Ophthalmology
- Infectious Disease
- Neurological Disorders
- Others
-
Europe Cell And Gene Therapy Market, by Delivery Method
- In Vivo
- Ex Vivo
-
Europe Cell And Gene Therapy Market, by End Users
- Hospitals
- Cancer Care Centers
- Others
- U. K.
- U.K. Cell And Gene Therapy Market, by Therapy Type
- Cell Therapy
- Gene Therapy
- U.K. Cell And Gene Therapy Market, by Therapeutic Class
- Cardiovascular Disease
- Cancer
- Genetic Disorder
- Rare Diseases
- Oncology
- Hematology
- Ophthalmology
- Infectious Disease
- Neurological Disorders
- Others
- U.K. Cell And Gene Therapy Market, by Delivery Method
- In Vivo
- Ex Vivo
- U.K. Cell And Gene Therapy Market, by End Users
- Hospitals
- Cancer Care Centers
- Others
- U.K. Cell And Gene Therapy Market, by Therapy Type
- France
- France Cell And Gene Therapy Market, by Therapy Type
- Cell Therapy
- Gene Therapy
- France Cell And Gene Therapy Market, by Therapeutic Class
- Cardiovascular Disease
- Cancer
- Genetic Disorder
- Rare Diseases
- Oncology
- Hematology
- Ophthalmology
- Infectious Disease
- Neurological Disorders
- Others
- France Cell And Gene Therapy Market, by Delivery Method
- In Vivo
- Ex Vivo
- France Cell And Gene Therapy Market, by End Users
- Hospitals
- Cancer Care Centers
- Others
- France Cell And Gene Therapy Market, by Therapy Type
-
Germany
- Germany Cell And Gene Therapy Market, by Therapy Type
- Cell Therapy
- Gene Therapy
- Germany Cell And Gene Therapy Market, by Therapeutic Class
- Cardiovascular Disease
- Cancer
- Genetic Disorder
- Rare Diseases
- Oncology
- Hematology
- Ophthalmology
- Infectious Disease
- Neurological Disorders
- Others
- Germany Cell And Gene Therapy Market, by Delivery Method
- In Vivo
- Ex Vivo
- Germany Cell And Gene Therapy Market, by End Users
- Hospitals
- Cancer Care Centers
- Others
- Germany Cell And Gene Therapy Market, by Therapy Type
-
Italy
- Italy Cell And Gene Therapy Market, by Therapy Type
- Cell Therapy
- Gene Therapy
- Italy Cell And Gene Therapy Market, by Therapeutic Class
- Cardiovascular Disease
- Cancer
- Genetic Disorder
- Rare Diseases
- Oncology
- Hematology
- Ophthalmology
- Infectious Disease
- Neurological Disorders
- Others
- Italy Cell And Gene Therapy Market, by Delivery Method
- In Vivo
- Ex Vivo
- Italy Cell And Gene Therapy Market, by End Users
- Hospitals
- Cancer Care Centers
- Others
- Italy Cell And Gene Therapy Market, by Therapy Type
-
Spain
- Spain Cell And Gene Therapy Market, by Therapy Type
- Cell Therapy
- Gene Therapy
- Spain Cell And Gene Therapy Market, by Therapeutic Class
- Cardiovascular Disease
- Cancer
- Genetic Disorder
- Rare Diseases
- Oncology
- Hematology
- Ophthalmology
- Infectious Disease
- Neurological Disorders
- Others
- Spain Cell And Gene Therapy Market, by Delivery Method
- In Vivo
- Ex Vivo
- Spain Cell And Gene Therapy Market, by End Users
- Hospitals
- Cancer Care Centers
- Others
- Spain Cell And Gene Therapy Market, by Therapy Type
-
Rest of Europe
- Rest of Europe Cell And Gene Therapy Market, by Therapy Type
- Cell Therapy
- Gene Therapy
- Rest of Europe Cell And Gene Therapy Market, by Therapeutic Class
- Cardiovascular Disease
- Cancer
- Genetic Disorder
- Rare Diseases
- Oncology
- Hematology
- Ophthalmology
- Infectious Disease
- Neurological Disorders
- Others
- Rest of Europe Cell And Gene Therapy Market, by Delivery Method
- In Vivo
- Ex Vivo
- Rest of Europe Cell And Gene Therapy Market, by End Users
- Hospitals
- Cancer Care Centers
- Others
- Rest of Europe Cell And Gene Therapy Market, by Therapy Type
-
Europe Cell And Gene Therapy Market, by Therapy Type
- Asia Pacific
-
Asia Pacific Cell And Gene Therapy Market, by Therapy Type
- Cell Therapy
- Gene Therapy
-
Asia Pacific Cell And Gene Therapy Market, by Therapeutic Class
- Cardiovascular Disease
- Cancer
- Genetic Disorder
- Rare Diseases
- Oncology
- Hematology
- Ophthalmology
- Infectious Disease
- Neurological Disorders
- Others
-
Asia Pacific Cell And Gene Therapy Market, by Delivery Method
- In Vivo
- Ex Vivo
-
Asia Pacific Cell And Gene Therapy Market, by End Users
- Hospitals
- Cancer Care Centers
- Others
- China
- China Cell And Gene Therapy Market, by Therapy Type
- Cell Therapy
- Gene Therapy
- China Cell And Gene Therapy Market, by Therapeutic Class
- Cardiovascular Disease
- Cancer
- Genetic Disorder
- Rare Diseases
- Oncology
- Hematology
- Ophthalmology
- Infectious Disease
- Neurological Disorders
- Others
- China Cell And Gene Therapy Market, by Delivery Method
- In Vivo
- Ex Vivo
- China Cell And Gene Therapy Market, by End Users
- Hospitals
- Cancer Care Centers
- Others
- China Cell And Gene Therapy Market, by Therapy Type
- Japan
- Japan Cell And Gene Therapy Market, by Therapy Type
- Cell Therapy
- Gene Therapy
- Japan Cell And Gene Therapy Market, by Therapeutic Class
- Cardiovascular Disease
- Cancer
- Genetic Disorder
- Rare Diseases
- Oncology
- Hematology
- Ophthalmology
- Infectious Disease
- Neurological Disorders
- Others
- Japan Cell And Gene Therapy Market, by Delivery Method
- In Vivo
- Ex Vivo
- Japan Cell And Gene Therapy Market, by End Users
- Hospitals
- Cancer Care Centers
- Others
- Japan Cell And Gene Therapy Market, by Therapy Type
-
Germany
- Germany Cell And Gene Therapy Market, by Therapy Type
- Cell Therapy
- Gene Therapy
- Germany Cell And Gene Therapy Market, by Therapeutic Class
- Cardiovascular Disease
- Cancer
- Genetic Disorder
- Rare Diseases
- Oncology
- Hematology
- Ophthalmology
- Infectious Disease
- Neurological Disorders
- Others
- Germany Cell And Gene Therapy Market, by Delivery Method
- In Vivo
- Ex Vivo
- Germany Cell And Gene Therapy Market, by End Users
- Hospitals
- Cancer Care Centers
- Others
- Germany Cell And Gene Therapy Market, by Therapy Type
-
India
- India Cell And Gene Therapy Market, by Therapy Type
- Cell Therapy
- Gene Therapy
- India Cell And Gene Therapy Market, by Therapeutic Class
- Cardiovascular Disease
- Cancer
- Genetic Disorder
- Rare Diseases
- Oncology
- Hematology
- Ophthalmology
- Infectious Disease
- Neurological Disorders
- Others
- India Cell And Gene Therapy Market, by Delivery Method
- In Vivo
- Ex Vivo
- India Cell And Gene Therapy Market, by End Users
- Hospitals
- Cancer Care Centers
- Others
- India Cell And Gene Therapy Market, by Therapy Type
-
South Korea
- South Korea Cell And Gene Therapy Market, by Therapy Type
- Cell Therapy
- Gene Therapy
- South Korea Cell And Gene Therapy Market, by Therapeutic Class
- Cardiovascular Disease
- Cancer
- Genetic Disorder
- Rare Diseases
- Oncology
- Hematology
- Ophthalmology
- Infectious Disease
- Neurological Disorders
- Others
- South Korea Cell And Gene Therapy Market, by Delivery Method
- In Vivo
- Ex Vivo
- South Korea Cell And Gene Therapy Market, by End Users
- Hospitals
- Cancer Care Centers
- Others
- South Korea Cell And Gene Therapy Market, by Therapy Type
-
South East Asia
- South East Asia Cell And Gene Therapy Market, by Therapy Type
- Cell Therapy
- Gene Therapy
- South East Asia Cell And Gene Therapy Market, by Therapeutic Class
- Cardiovascular Disease
- Cancer
- Genetic Disorder
- Rare Diseases
- Oncology
- Hematology
- Ophthalmology
- Infectious Disease
- Neurological Disorders
- Others
- South East Asia Cell And Gene Therapy Market, by Delivery Method
- In Vivo
- Ex Vivo
- South East Asia Cell And Gene Therapy Market, by End Users
- Hospitals
- Cancer Care Centers
- Others
- South East Asia Cell And Gene Therapy Market, by Therapy Type
-
Rest of Asia Pacific
- Rest of Asia Pacific Cell And Gene Therapy Market, by Therapy Type
- Cell Therapy
- Gene Therapy
- Rest of Asia Pacific Cell And Gene Therapy Market, by Therapeutic Class
- Cardiovascular Disease
- Cancer
- Genetic Disorder
- Rare Diseases
- Oncology
- Hematology
- Ophthalmology
- Infectious Disease
- Neurological Disorders
- Others
- Rest of Asia Pacific Cell And Gene Therapy Market, by Delivery Method
- In Vivo
- Ex Vivo
- Rest of Asia Pacific Cell And Gene Therapy Market, by End Users
- Hospitals
- Cancer Care Centers
- Others
- Rest of Asia Pacific Cell And Gene Therapy Market, by Therapy Type
-
Asia Pacific Cell And Gene Therapy Market, by Therapy Type
- Latin America
-
Latin America Cell And Gene Therapy Market, by Therapy Type
- Cell Therapy
- Gene Therapy
-
Latin America Cell And Gene Therapy Market, by Therapeutic Class
- Cardiovascular Disease
- Cancer
- Genetic Disorder
- Rare Diseases
- Oncology
- Hematology
- Ophthalmology
- Infectious Disease
- Neurological Disorders
- Others
-
Latin America Cell And Gene Therapy Market, by Delivery Method
- In Vivo
- Ex Vivo
-
Latin America Cell And Gene Therapy Market, by End Users
- Hospitals
- Cancer Care Centers
- Others
- Brazil
- Brazil Cell And Gene Therapy Market, by Therapy Type
- Cell Therapy
- Gene Therapy
- Brazil Cell And Gene Therapy Market, by Therapeutic Class
- Cardiovascular Disease
- Cancer
- Genetic Disorder
- Rare Diseases
- Oncology
- Hematology
- Ophthalmology
- Infectious Disease
- Neurological Disorders
- Others
- Brazil Cell And Gene Therapy Market, by Delivery Method
- In Vivo
- Ex Vivo
- Brazil Cell And Gene Therapy Market, by End Users
- Hospitals
- Cancer Care Centers
- Others
- Brazil Cell And Gene Therapy Market, by Therapy Type
- Argentina
- Argentina Cell And Gene Therapy Market, by Therapy Type
- Cell Therapy
- Gene Therapy
- Argentina Cell And Gene Therapy Market, by Therapeutic Class
- Cardiovascular Disease
- Cancer
- Genetic Disorder
- Rare Diseases
- Oncology
- Hematology
- Ophthalmology
- Infectious Disease
- Neurological Disorders
- Others
- Argentina Cell And Gene Therapy Market, by Delivery Method
- In Vivo
- Ex Vivo
- Argentina Cell And Gene Therapy Market, by End Users
- Hospitals
- Cancer Care Centers
- Others
- Argentina Cell And Gene Therapy Market, by Therapy Type
-
Rest of Latin America
- Rest of Latin America Cell And Gene Therapy Market, by Therapy Type
- Cell Therapy
- Gene Therapy
- Rest of Latin America Cell And Gene Therapy Market, by Therapeutic Class
- Cardiovascular Disease
- Cancer
- Genetic Disorder
- Rare Diseases
- Oncology
- Hematology
- Ophthalmology
- Infectious Disease
- Neurological Disorders
- Others
- Rest of Latin America Cell And Gene Therapy Market, by Delivery Method
- In Vivo
- Ex Vivo
- Rest of Latin America Cell And Gene Therapy Market, by End Users
- Hospitals
- Cancer Care Centers
- Others
- Rest of Latin America Cell And Gene Therapy Market, by Therapy Type
-
Latin America Cell And Gene Therapy Market, by Therapy Type
- Middle East & Africa
-
Middle East & Africa Cell And Gene Therapy Market, by Therapy Type
- Cell Therapy
- Gene Therapy
-
Middle East & Africa Cell And Gene Therapy Market, by Therapeutic Class
- Cardiovascular Disease
- Cancer
- Genetic Disorder
- Rare Diseases
- Oncology
- Hematology
- Ophthalmology
- Infectious Disease
- Neurological Disorders
- Others
-
Middle East & Africa Cell And Gene Therapy Market, by Delivery Method
- In Vivo
- Ex Vivo
-
Middle East & Africa Cell And Gene Therapy Market, by End Users
- Hospitals
- Cancer Care Centers
- Others
- GCC Countries
- GCC Countries Cell And Gene Therapy Market, by Therapy Type
- Cell Therapy
- Gene Therapy
- GCC Countries Cell And Gene Therapy Market, by Therapeutic Class
- Cardiovascular Disease
- Cancer
- Genetic Disorder
- Rare Diseases
- Oncology
- Hematology
- Ophthalmology
- Infectious Disease
- Neurological Disorders
- Others
- GCC Countries Cell And Gene Therapy Market, by Delivery Method
- In Vivo
- Ex Vivo
- GCC Countries Cell And Gene Therapy Market, by End Users
- Hospitals
- Cancer Care Centers
- Others
- GCC Countries Cell And Gene Therapy Market, by Therapy Type
- South Africa
- South Africa Cell And Gene Therapy Market, by Therapy Type
- Cell Therapy
- Gene Therapy
- South Africa Cell And Gene Therapy Market, by Therapeutic Class
- Cardiovascular Disease
- Cancer
- Genetic Disorder
- Rare Diseases
- Oncology
- Hematology
- Ophthalmology
- Infectious Disease
- Neurological Disorders
- Others
- South Africa Cell And Gene Therapy Market, by Delivery Method
- In Vivo
- Ex Vivo
- South Africa Cell And Gene Therapy Market, by End Users
- Hospitals
- Cancer Care Centers
- Others
- South Africa Cell And Gene Therapy Market, by Therapy Type
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Cell And Gene Therapy Market, by Therapy Type
- Cell Therapy
- Gene Therapy
- Rest of Middle East & Africa Cell And Gene Therapy Market, by Therapeutic Class
- Cardiovascular Disease
- Cancer
- Genetic Disorder
- Rare Diseases
- Oncology
- Hematology
- Ophthalmology
- Infectious Disease
- Neurological Disorders
- Others
- Rest of Middle East & Africa Cell And Gene Therapy Market, by Delivery Method
- In Vivo
- Ex Vivo
- Rest of Middle East & Africa Cell And Gene Therapy Market, by End Users
- Hospitals
- Cancer Care Centers
- Others
- Rest of Middle East & Africa Cell And Gene Therapy Market, by Therapy Type
-
Middle East & Africa Cell And Gene Therapy Market, by Therapy Type
- North America
FAQ
Frequently Asked Question
What is the global demand for Cell And Gene Therapy in terms of revenue?
-
The global Cell And Gene Therapy valued at USD 20.5 Billion in 2023 and is expected to reach USD 128.8 Billion in 2032 growing at a CAGR of 18.2%.
Which are the prominent players in the market?
-
The prominent players in the market are Alnylam Pharmaceuticals Inc., Amgen Inc., Biogen Inc., CORESTEM Inc., Dendreon Pharmaceuticals LLC., Helixmith Co. Ltd., JCR Pharmaceuticals Co. Ltd., Kolon TissueGene Inc., Novartis AG, Pfizer Inc..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 18.2% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Cell And Gene Therapy include
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Cell And Gene Therapy in 2023.
